The project is a consortium of a research institute (TU/e), an academic hospital (Erasmus MC, Rotterdam) and a company (Sensius Thermotherapy) that aims to facilitate the widespread adoption of thermotherapy by developing a comprehensive quality assurance program to control real-time dosimetry. Clinical studies showed that thermotherapy, heating of tumors to 40-44˚C, significantly enhances the therapeutic efficacy of radiotherapy and chemotherapy without adding side effects.